JANES, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 4.423
AS - Asia 1.969
EU - Europa 1.492
SA - Sud America 319
Continente sconosciuto - Info sul continente non disponibili 173
AF - Africa 54
OC - Oceania 6
Totale 8.436
Nazione #
US - Stati Uniti d'America 4.317
SG - Singapore 956
IT - Italia 476
CN - Cina 357
BR - Brasile 243
UA - Ucraina 203
DE - Germania 181
HK - Hong Kong 180
RU - Federazione Russa 141
VN - Vietnam 122
FI - Finlandia 94
FR - Francia 94
GB - Regno Unito 70
BD - Bangladesh 69
IN - India 68
CA - Canada 62
IE - Irlanda 52
SE - Svezia 40
AR - Argentina 30
PL - Polonia 28
TR - Turchia 25
NL - Olanda 24
KR - Corea 22
JP - Giappone 21
IL - Israele 20
IQ - Iraq 20
ES - Italia 19
MX - Messico 16
IR - Iran 15
PK - Pakistan 14
ZA - Sudafrica 14
BE - Belgio 12
AT - Austria 11
EC - Ecuador 11
CO - Colombia 10
CZ - Repubblica Ceca 10
SA - Arabia Saudita 9
UZ - Uzbekistan 9
PH - Filippine 7
VE - Venezuela 7
AL - Albania 6
CL - Cile 6
DZ - Algeria 6
EG - Egitto 6
ID - Indonesia 6
JO - Giordania 6
CH - Svizzera 5
DK - Danimarca 5
JM - Giamaica 5
LT - Lituania 5
MA - Marocco 5
MY - Malesia 5
NP - Nepal 5
SC - Seychelles 5
TG - Togo 5
TN - Tunisia 5
AU - Australia 4
PT - Portogallo 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
AZ - Azerbaigian 3
BO - Bolivia 3
CR - Costa Rica 3
EU - Europa 3
HN - Honduras 3
HU - Ungheria 3
OM - Oman 3
PA - Panama 3
SN - Senegal 3
TH - Thailandia 3
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
PR - Porto Rico 2
QA - Qatar 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BS - Bahamas 1
BZ - Belize 1
ET - Etiopia 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KY - Cayman, isole 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
MC - Monaco 1
Totale 8.254
Città #
Singapore 444
Ashburn 414
San Jose 347
Ann Arbor 338
Woodbridge 280
Chandler 271
Fairfield 191
Hong Kong 177
Council Bluffs 173
Beijing 168
Houston 144
Jacksonville 138
Dearborn 114
Boardman 97
Wilmington 89
Seattle 80
Los Angeles 75
Lauterbourg 66
Cambridge 58
Dublin 52
Princeton 51
Dallas 50
Trieste 48
Udine 48
Munich 45
New York 45
São Paulo 37
Venezia 36
Buffalo 33
Ho Chi Minh City 33
Milan 33
Santa Clara 28
Warsaw 26
Hefei 25
Tavagnacco 25
Phoenix 24
Helsinki 23
Rome 23
Hanoi 21
Redondo Beach 21
San Diego 21
Montreal 20
Frankfurt am Main 19
Seoul 19
The Dalles 19
Mumbai 18
Ogden 18
Toronto 17
Nuremberg 16
Tokyo 16
Chicago 15
Redmond 15
Brooklyn 14
Dong Ket 14
Orem 14
Boydton 13
Norwalk 13
Stockholm 13
Brussels 12
Izmir 12
London 11
Atlanta 10
Boston 10
Buenos Aires 10
Codroipo 10
Denver 10
Poplar 10
San Francisco 10
Düsseldorf 9
Amsterdam 8
Guangzhou 8
Haiphong 8
Johannesburg 8
Lappeenranta 8
Tashkent 8
Zanjan 8
Baghdad 7
Belo Horizonte 7
Bologna 7
Brno 7
Florence 7
Hyderabad 7
Mexico City 7
Naples 7
North Bergen 7
Amman 6
Andover 6
Birmingham 6
Brasília 6
Chennai 6
Des Moines 6
Falls Church 6
Kunming 6
Pune 6
Riyadh 6
Shanghai 6
Washington 6
Ankara 5
Cagliari 5
Campo Grande 5
Totale 5.005
Nome #
MARKERS BIOLOGICI DI RICANALIZZAZIONE E DI EFFICACIA CLINICA DEL TRATTAMENTO CON r-tPA NELL'ICTUS CEREBRALE ISCHEMICO ACUTO 240
Are Early Seizures Predictive of Epilepsy after a Stroke? Results of a Population-Based Study 233
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 230
A case of myelitis with features of late onset systemic lupus erythematosus 202
Changes of cortical excitability after dopaminergic treatment in restless legs syndrome 194
Incidence of transient ischemic attack and early stroke risk: validation of the ABCD2 score in an Italian population-based study. 185
Brain Endothelial Cells Activate Neuroinflammatory Pathways in Response to Early Cerebral Small Vessel Disease (CSVD) Patients’ Plasma 172
Prevalence of Restless Legs Syndrome in Migraine Patients: A Case-Control Study. Analysis of Risk Factors for Restless Legs Syndrome in Migraine Patients 172
Prediction of late seizures after ischaemic stroke with a novel prognostic model (the SeLECT score): a multivariable prediction model development and validation study 169
ABCD2 score validation in Italy. Tia incidence and 2, 7, 30 and 90-day stroke risk 163
Electroencephalographic Evaluation for Early Diagnosis of Limbic Encephalitis 163
Asymmetrical Dimethylarginine (ADMA) In Asympomatic Cerebral Small Vessel Disease. 158
6 months post-stroke depression: prevalence and outcome correlation in Udine, Italy 152
Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population based study 152
ABD2 SCORE VALIDATION IN ITALY. TIA INCIDENCE AND 2, 7, 30 AND 90 DAY STROKE RISK 149
Comparison of pharmacokinetic properties of alteplase and tenecteplase. The future of thrombolysis in acute ischemic stroke 145
Identification of stroke etiology may contribute to improve the outcome in dedicated units 145
Stroke incidence and 28-day case fatality rates: the Udine stroke registry 141
Cerebrovascular risk in restless legs syndrome: Intima-media thickness and cerebral vasomotor reactivity: A case–control study 141
A case of recurrent cerebral embolic ischemic stroke caused by atrial myxoma 141
G. Crossed aphasia: a case report 139
Attacco ischemico transitorio e rischio di ictus a breve termine. 138
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 133
Crossed aphasia: a case report. 131
Alpha-synuclein seeds in olfactory mucosa and cerebrospinal fluid of patients with dementia with Lewy bodies 131
Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination 131
Transient Ischemic attack incidence and 28-day prognosis: the Udine stroke registry 130
NBIA: genetic-clinic-radiologic correlation in a family setting of PANK2 mutation 129
Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report 126
Stroke incidence, 6-months case fatalithy rates and out come in Udine, Italy. A population-based prospective study 124
Transient Ischemic Attack Incidence and 2-, 7- and 30-Day Prognosis in Udine, Italy. A Population-Based Prospective Study 123
Stroke incidence, 6-months case fatality rates and out come in Udine, Italy. A population-based prospective study 121
Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects 119
Clinical and functional determinants of appropriate rehabilitation referrals after stroke: a single-center retrospective cohort study 115
Clinical and neurophysiological effects of botulinum neurotoxin type a in chronic migraine 111
A large biomarker investigation in young asymptomatic patients with cerebral vessel disease identified ADMA as a possible key molecule driving endothelial damage. 110
Seizures after ischemic stroke: a matched multicenter study 110
Brain Exosomes: Friend or Foe in Alzheimer’s Disease? 110
The effect of drugs with anticholinergic activity on cognitive and neuropsychiatric symptoms in Alzheimer disease 109
NBIA: genetic-clinic-radiologic correlation in a family setting of pank2 mutation. In: Neurological Sciences. 108
Novel Associations of BST1 and LAMP3 with Rapid Eye Movement Sleep Behavior Disorder 108
Letter by D'Anna et al regarding article, "Long-term mortality in patients with stroke of undetermined etiology". 107
Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model 104
May lamotrigine be an alternative to topiramate in the prevention of migraine with aura? Results of a retrospective study 104
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease 102
Stroke Unit care versus Medical Ward for acute ischemic stroke patients: an observational follow-up study 101
Pretreatment d-dimer levels in acute ischemic stroke predict reperfusion after intravenous thrombolysis 99
Post-stroke seizures and epilepsy: incidence and predictors in a population based study 98
NPC1 variants are not associated with Parkinson's disease, REM-sleep behavior disorder or dementia with Lewy bodies in European cohorts 97
The use of alteplase, although safe, does not offer clear clinical advantages when mild stroke is non-disabling 97
Stroke incidence and 30-day case fatality rates in Udine, Italy : a population-based prospective study 96
Predictors of letality and of 30 days and 6 months functional impairment in Udine stroke registry 93
Mid‐Regional Proadrenomedullin Can Be Reliably Measured in Cerebrospinal Fluid to Improve Diagnosis of Central Nervous System Diseases 92
Post-Stroke Status Epilepticus: Time of Occurrence May Be the Difference? 92
Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19 90
null 90
The Effect of Serum of Cerebral Small Vessel Disease Patients on Brain Endothelial Cells 90
Failure of Therapeutic Anticoagulation in COVID-19 Patients With Acute Ischemic Stroke. A Retrospective Multicenter Study 90
Response to Letter to the Editor on the article “Acute disseminated encephalomyelitis after SARS-CoV-2 vaccination” 87
HLA in isolated REM sleep behavior disorder and Lewy body dementia 86
Contribution and Effectiveness of Laboratory Testing in the Diagnostic Assessment of Juvenile Ischemic Stroke and Transient Ischemic Attack 83
Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder 81
Correction: Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease (Translational Neurodegeneration, (2022), 11, 1, (37), 10.1186/s40035-022-00311-3) 79
Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder 79
Stroke incidence and 30-day and six-month case fatality rates in Udine, Italy: a population-based prospective study 74
Stroke incidence and 30-day and six-month case fatality rates in Udine, Italy: a population-based prospective study. 69
Lack of epistatic interaction of SNCA with APOE in synucleinopathies 58
Mid-Regional Proadrenomedullin in Cerebrospinal Fluid Is a Reliable Diagnostic and Prognostic Marker for Acute Meningoencephalitis and Neurological Disorders 48
Critically appraised topic on Rapid Eye Movement Behavior Disorder: From protein misfolding processes to clinical pathophysiology and conversion to neurodegenerative disorders 47
Totale 8.436
Categoria #
all - tutte 33.604
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.604


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022353 0 0 0 0 12 17 24 20 8 64 129 79
2022/2023609 56 49 6 88 48 165 4 47 69 7 32 38
2023/2024305 33 16 17 4 26 44 6 14 33 37 9 66
2024/20251.428 28 91 69 51 100 74 91 103 206 111 228 276
2025/20262.717 251 245 153 246 452 190 340 80 222 206 233 99
2026/2027836 80 139 219 394 4 0 0 0 0 0 0 0
Totale 8.436